Economic Evaluation of Health Care Programs, September 29 – October 02, 2008


Introduction to Cost-Effectiveness Analysis:
1. Current Concepts
2. Controversies
3. International Experience



Monday (Sept. 29th) – From 10:00 am to 8:00 pm

Current Concepts

—

Economic Evaluation of Health Care Programs: A Typology
    Michael Schlander

—

Valuation of Outcomes: Willingness-to-Pay and Health-Adjusted Life Years
    Michael Schlander

—

Preferences as a Latent Construct
    Darcey Terris

—

The Concept of Utility and the Role of von Neumann-Morgenstern Expected Utility Theory (EUT)
    Jeff Richardson

—

Quantifying “Quality of Life” (Exercise)
    Michael Schlander



Tuesday (Sept. 30th) - From 9:00 am to 8:00 pm

Current Concepts and Controversies

—

Insights from Exercise
    Michael Schlander

—

Economic Welfare Theory & Cost-Benefit Analysis
    Friedrich Breyer

—

Measuring Social Preferences for Priority-Setting
    Erik Nord

—

Outline of a Fairness-Based Evaluation Framework
    Jeff Richardson

—Lunch —

—

Extrawelfarism: The Logic of Cost-Effectiveness
    Martin J. Buxton

—

Priority-Setting in Health Care: Focus on Fair Process?
    Sören Holm

—

Discussion with the Experts
    Friedrich Breyer,
    Martin J. Buxton
    Sören Holm
    Erik Nord
    Jeff Richardson
    Michael Schlander

—Afternoon Tea —

International Experience I

—

Health Technology Assessments (HTAs) in Europe
    Panos G. Kanavos

—

NICE and the NHS
    Martin J. Buxton



Wednesday (Oct. 01st) - From 9:00 am to 9:00 pm

International Experience II

—

Recent Developments in England, including “Value-Based Pricing”
    Martin J. Buxton

—

North America: CEA in Canada and the United States
    Peter J. Neumann

—

CEA and CUA: Common Methodological Flaws
    Peter J. Neumann

—

Discussion with the Experts
    Martin J. Buxton
    Panos G. Kanavos
    Peter J. Neumann

—Lunch —

International Experience III

—

Australia: The Pharmaceutical Benefits Scheme (PBS)
    Rosalie Viney

—

The Role of Quality-Adjusted Life Years (QALYs)
    Rosalie Viney

—Afternoon Tea —

International Experience IV

—

Sweden: The Pharmaceutical Benefits Board (LFN)
    Ulf Persson

—

Advanced Modeling Techniques: Appropriate Use and International Acceptance
    Jaime Caro



Thursday (Oct. 02nd) - From 9:00 am to 3:00 pm

International Experience V

—

IQWiG: Economic Evaluation in Germany
    Jaime Caro and Peter Kolominsky-Rabas

—

HAS: Economic Evaluation in France
    Gérard de Pouvourville

—

Discussion with the Experts
    Jaime Caro
    Peter Kolominsky-Rabas
    Erik Nord
    Ulf Persson
    Gérard de Pouvourville
    Rosalie Viney

Stakeholder Perspectives

—

International Pharmaceutical Industry
    Koen Torfs

—

Health Care Policy Makers
    Wolfgang Kaesbach

Discussion and Conclusions

—

Which Way Forward?
    Michael Schlander



Disclaimer

Please note that situations may arise in the future that require change and revision of the program.